Adagio Medical Holdings (ADGM) Depreciation & Amortization (CF) (2023 - 2026)
Adagio Medical Holdings (ADGM) reported Depreciation & Amortization (CF) of $210000.0 for Q1 2026, down 22.51% on a YoY basis from $271000.0 in Q1 2025, and down 11.39% sequentially from $237000.0 in Q4 2025.
Adagio Medical Holdings (ADGM) Depreciation & Amortization (CF) (2023 - 2026) Analysis & Trends
Adagio Medical Holdings (ADGM) has 4 years of Depreciation & Amortization (CF) data on file, last reported at $210000.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation & Amortization (CF) fell 22.51% year-over-year to $210000.0; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (up 27.02% YoY), and the FY2025 full-year result was $970000.0, up 31.08% from the prior year.
- Depreciation & Amortization (CF) slipped to $210000.0 in Q1 2026, from $237000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $500000.0 in Q3 2025 to a low of $100000.0 in Q3 2023.
- A 4-year average of $261300.0 and a median of $254000.0 in 2025 frame the typical range for Depreciation & Amortization (CF).
- Across the five-year window, Depreciation & Amortization (CF) jumped 216.0% in 2024 and slumped 36.71% in 2025, its largest moves.
- Tracing ADGM's Depreciation & Amortization (CF) over 4 years: stood at $133000.0 in 2023, then surged by 137.59% to $316000.0 in 2024, then dropped by 25.0% to $237000.0 in 2025, then fell by 11.39% to $210000.0 in 2026.
- Business Quant data shows ADGM's Depreciation & Amortization (CF) at $210000.0 in Q1 2026, $237000.0 in Q4 2025, and $500000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 67.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 310.25 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Adagio Medical Holdings | 21.49 Mn | 21.49 Mn | - | 210,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 210,000.00 |
| Mar 31, 2026 | 210,000.00 |
| Dec 31, 2025 | 237,000.00 |
| Dec 31, 2025 | 237,000.00 |
| Sep 30, 2025 | 500,000.00 |
| Sep 30, 2025 | 500,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Mar 31, 2025 | 271,000.00 |
| Mar 31, 2025 | 271,000.00 |
| Sep 30, 2024 | 316,000.00 |
| Sep 30, 2024 | 316,000.00 |
| Jun 30, 2024 | 316,000.00 |
| Jun 30, 2024 | 316,000.00 |
| Mar 31, 2024 | 330,000.00 |
| Mar 31, 2024 | 330,000.00 |
| Dec 31, 2023 | 133,000.00 |
| Dec 31, 2023 | 133,000.00 |
| Sep 30, 2023 | 100,000.00 |
| Sep 30, 2023 | 100,000.00 |